KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec LLC, a subsidiary of Julphar. This acquisition strengthens ...

UAE - Kelix bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar. This acquisition strengthens ...

The Mubadala Abu Dhabi Open just got more exciting as four more players—Caroline Garcia, Marketa Vondrousova, Ashlyn Krueger, and Wakana Sonobe—have been confirmed for the star-studded WTA 500 ...

Getir’s founding team had previously clashed with investors, primarily Mubadala, over the company’s strategy and costs. Its valuation plunged to $2.5 billion in 2023 from its peak of $11.8 ...

Mubadala Capital, the investment arm of Abu Dhabi’s sovereign wealth fund, has secured a majority stake in the high-profile baby buggy manufacturer Bugaboo. This strategic acquisition underscores ...

A strategic move that further supports Mubadala’s efforts to advance the UAE's life sciences sector Following the acquisition of four GlobalOne Healthcare Holding assets, this transaction represents ...

Getir founders allege Mubadala breached restructuring agreement Mubadala claims founders failed to complete June agreement Mubadala says it will present new plan to Getir shareholders in coming ...

A founder of Turkish fast-delivery company Getir announced on Wednesday he would pursue legal action against what he called an "illegal coup" by Mubadala, the firm's largest shareholder, which was ...

Dubai-headquartered Kelix Bio, wholly owned by Abu Dhabi’s Mubadala Investment (Mubadala), has completed the acquisition of insulin manufacturer DiabTec, a subsidiary of Ras Al Khaimah-headquartered ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Kelix bio, an emerging markets-focused specialty generic biopharmaceutical company has struck its fifth strategic deal since its acquisition by Abu Dhabi sovereign investor Mubadala Investment Company ...